Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 367

Similar articles for PubMed (Select 17127399)


Cell dynamics and immune response to BLV infection: a unifying model.

Florins A, Gillet N, Asquith B, Boxus M, Burteau C, Twizere JC, Urbain P, Vandermeers F, Debacq C, Sanchez-Alcaraz MT, Schwartz-Cornil I, Kerkhofs P, Jean G, Théwis A, Hay J, Mortreux F, Wattel E, Reichert M, Burny A, Kettmann R, Bangham C, Willems L.

Front Biosci. 2007 Jan 1;12:1520-31. Review.


Discordance between bovine leukemia virus tax immortalization in vitro and oncogenicity in vivo.

Twizere JC, Kerkhofs P, Burny A, Portetelle D, Kettmann R, Willems L.

J Virol. 2000 Nov;74(21):9895-902.


Reduced proviral loads during primo-infection of sheep by Bovine Leukemia virus attenuated mutants.

Debacq C, Sanchez Alcaraz MT, Mortreux F, Kerkhofs P, Kettmann R, Willems L.

Retrovirology. 2004 Oct 5;1:31.


Complete suppression of viral gene expression is associated with the onset and progression of lymphoid malignancy: observations in Bovine Leukemia Virus-infected sheep.

Merimi M, Klener P, Szynal M, Cleuter Y, Bagnis C, Kerkhofs P, Burny A, Martiat P, Van den Broeke A.

Retrovirology. 2007 Jul 23;4:51.


Bovine leukaemia virus-induced lymphocytosis in sheep is associated with reduction of spontaneous B cell apoptosis.

Schwartz-Cornil I, Chevallier N, Belloc C, Le Rhun D, Lainé V, Berthelemy M, Mateo A, Levy D.

J Gen Virol. 1997 Jan;78 ( Pt 1):153-62.


Ex vivo survival of peripheral blood mononuclear cells in sheep induced by bovine leukemia virus (BLV) mainly occurs in CD5- B cells that express BLV.

Takahashi M, Tajima S, Takeshima SN, Konnai S, Yin SA, Okada K, Davis WC, Aida Y.

Microbes Infect. 2004 May;6(6):584-95.


Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep.

Debacq C, Asquith B, Kerkhofs P, Portetelle D, Burny A, Kettmann R, Willems L.

Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10048-53. Epub 2002 Jul 15.


Up-regulation of tumor necrosis factor alpha mRNA is associated with bovine-leukemia virus (BLV) elimination in the early phase of infection.

Kabeya H, Ohashi K, Oyunbileg N, Nagaoka Y, Aida Y, Sugimoto C, Yokomizo Y, Onuma M.

Vet Immunol Immunopathol. 1999 May;68(2-4):255-65.


Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.

Merezak C, Pierreux C, Adam E, Lemaigre F, Rousseau GG, Calomme C, Van Lint C, Christophe D, Kerkhofs P, Burny A, Kettmann R, Willems L.

J Virol. 2001 Aug;75(15):6977-88.


Pathogenicity of molecularly cloned bovine leukemia virus.

Rovnak J, Boyd AL, Casey JW, Gonda MA, Jensen WA, Cockerell GL.

J Virol. 1993 Dec;67(12):7096-105.


Emphasis on cell turnover in two hosts infected by bovine leukemia virus: a rationale for host susceptibility to disease.

Florins A, Boxus M, Vandermeers F, Verlaeten O, Bouzar AB, Defoiche J, Hubaux R, Burny A, Kettmann R, Willems L.

Vet Immunol Immunopathol. 2008 Sep 15;125(1-2):1-7. doi: 10.1016/j.vetimm.2008.04.007. Epub 2008 Apr 16. Review.


Bovine leukemia virus-induced persistent lymphocytosis in cattle does not correlate with increased ex vivo survival of B lymphocytes.

Dequiedt F, Cantor GH, Hamilton VT, Pritchard SM, Davis WC, Kerkhofs P, Burny A, Kettmann R, Willems L.

J Virol. 1999 Feb;73(2):1127-37.


Reduced cell turnover in bovine leukemia virus-infected, persistently lymphocytotic cattle.

Debacq C, Asquith B, Reichert M, Burny A, Kettmann R, Willems L.

J Virol. 2003 Dec;77(24):13073-83.


Genetic determinants of bovine leukemia virus pathogenesis.

Willems L, Burny A, Collete D, Dangoisse O, Dequiedt F, Gatot JS, Kerkhofs P, Lefèbvre L, Merezak C, Peremans T, Portetelle D, Twizere JC, Kettmann R.

AIDS Res Hum Retroviruses. 2000 Nov 1;16(16):1787-95. Review.


In vivo leukocyte tropism of bovine leukemia virus in sheep and cattle.

Schwartz I, Bensaid A, Polack B, Perrin B, Berthelemy M, Levy D.

J Virol. 1994 Jul;68(7):4589-96.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk